menu search

Poolbeg's lead asset to be in the spotlight at leading medical conference

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said the potential of its lead asset will be discussed at a leading medical conference in December. A poste...

November 3, 2023, 3:32 am

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

New data on the completed dose-escalation of this Phase 1 trial highlights promising efficacy of INB-100 in patients with hematologic malignancies; up...

November 2, 2023, 1:17 pm

Autolus therapeutics reports third quarter 2023 financial results and business updates

Obe-cel, a potentially transformational treatment for relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (ALL), on track for a Biolog...

November 2, 2023, 11:11 am

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...

November 2, 2023, 9:17 am

Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition

BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...

November 2, 2023, 9:15 am

Vincerx pharma to present three posters at ash 2023 in december

VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...

November 2, 2023, 9:10 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (...

November 2, 2023, 2:00 am

hematology analyzers market poised to reach $2.20 billion by 2033 amid rising pediatric blood disorder cases and continuous innovation: report by persistence market research

Rising blood disorder prevalence propels the U.S. to capture 90.3% market share in North America’s hematolog...

October 25, 2023, 11:16 am

Retinalgenix technologies, inc. nears completion of institutional review board for research on dna/gps program

Study Intends To Identify hematology Biomarkers That May Help Personalize Medical Evaluations For Patie...

June 26, 2023, 10:15 am

Kura oncology presents late-breaking clinical data for menin inhibitor ziftomenib at 2023 european hematology association (eha) congress

– 35% CR rate (7/20) among patients with relapsed/refractory NPM1-mutant AML treated at 600 mg dose (RP2D) – – 33% (2/6) of patients with FLT3 c...

June 11, 2023, 7:45 am

Nkarta presents nkx019 clinical data at the european hematology association 2023 congress and 17th international conference on malignant lymphoma

7 of 10 r/r NHL patients achieved complete response (70% CR rate) following treatment with NKX019 monotherapy at 1 billion and 1.5 billion CAR NK cell...

June 10, 2023, 2:47 pm

Cellectis presents updated clinical and translational data on balli-01 at the european hematology association (eha) 2023

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology c...

June 9, 2023, 8:30 pm

Disc presents positive initial data from phase 2 beacon trial of bitopertin in patients with erythropoietic protoporphyria (epp) at european hematology association (eha) 2023 congress

Consistent and dose-dependent reductions of protoporphyrin IX (PPIX), the disease-causing metabolite in EPP, were observed in patients treated with bi...

June 9, 2023, 11:00 am

Astrazeneca plc (azn) asco investor event

AstraZeneca PLC (NASDAQ:AZN ) ASCO Investor Event June 5, 2023 7:00 PM ET CorporateParticipants Andy Barnett - VP Global Head of IR Roy Herbst - Deput...

June 6, 2023, 7:17 am

Regeneron pharmaceuticals, inc. (regn) td cowen 4th annual oncology innovation summit (transcript)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) TD Cowen 4th Annual Oncology Innovation Summit May 30, 2023 12:30 PM ET Company Participants Izzy Lowy ...

May 30, 2023, 3:18 pm

Innate pharma to present iph6501 preclinical data at the eha 2023 congress

MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced ...

May 15, 2023, 1:00 am

Gracell biotechnologies to present clinical data on bcma/cd19 dual-targeting fastcar-t gc012f in rrmm and b-nhl and donor-derived car-t gc007g in b-all at eha2023 congress

First disclosure of data from Phase 1 study of the donor-derived allogeneic CAR-T GC007g shows 100% overall response rate (ORR) and a favorable safety...

May 11, 2023, 5:28 pm

Editas medicine to present clinical data from the ruby trial of edit-301 for the treatment of severe sickle cell disease at the eha 2023 congress

CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced tha...

May 11, 2023, 10:32 am


Search within

Pages Search Results: